Oncogenic reg IV is a novel prognostic marker for glioma patient survival

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Wang, Qi ^a   Deng, Jianping ^a   Yuan, Jun ^a   Wang, Liang ^a   Zhao, Zhenwei ^a   He, Shiming ^a   Zhang, Yongsheng ^a   Tu, Yanyang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

glioma; Immunohistochemistry; Prognosis; Regenerating islet derived family member 4; RT PCR; Western blot

Indexed keywords

LECTIN; MESSENGER RNA; REG4 PROTEIN, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER GRADING; CHEMISTRY; CHILD; FEMALE; GENETICS; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; TIME; UPREGULATION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; BRAIN NEOPLASMS; CHILD; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; LECTINS, C-TYPE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 84862303801     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-69     Document Type: Article

References (26)

1. Rousseau A, Mokhtari K, Duyckaerts C. The 2007 WHO classification of tumors of the central nervous system - what has changed?. Curr Opin Neurol 2008, 21:720-727. 10.1097/WCO.0b013e328312c3a7, 18989119.
2. Stylli SS, Howes M, MacGregor L, Rajendra P, Kaye AH. Photodynamic therapy of brain tumours : evaluation of porphyrin uptake versus clinical outcome. J Clin Neurosci 2004, 11:584-596. 10.1016/j.jocn.2004.02.001, 15261226.
3. Stylli SS, Howes M, MacGregor L, Kaye AH. Photodynamic therapy of high grade glioma-long term survival. J Clin Neurosci 2005, 12:385-394.
4. Zhang X, Yang H, Gong B, Jiang C, Yang L. Combined gene expression and protein interaction analysis of dynamic modularity in glioma prognosis. J Neurooncol 2012, 107:281-288. 10.1007/s11060-011-0757-4, 22071792.
5. Yamagishi H, Fukui H, Sekikawa A, Kono T, Fujii S, Ichikawa K, Tomita S, Imura J, Hiraishi H, Chiba T, Fujimori T. Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers. Mod Pathol 2009, 22:906-913. 10.1038/modpathol.2009.41, 19329938.
6. Zhang YW, Ding LS, Lai MD. Reg gene family and human diseases. World J Gastroenterol 2003, 9:2635-2641.
7. Li YG, Ji DF, Zhong S, Zhu JX, Chen S, Hu GY. Anti-tumor effects of proteoglycan from Phellinus linteus by immunomodulating and inhibiting Reg IV/EGFR/Akt signaling pathway in colorectal carcinoma. Int J Biol Macromol 2011, 48:511-517. 10.1016/j.ijbiomac.2011.01.014, 21262260.
8. Hartupee JC, Zhang H, Bonaldo MF, Soares MB, Dieckgraefe BK. Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: Reg IV. Biochim Biophys Acta 2001, 1518:287-293. 10.1016/S0167-4781(00)00284-0, 11311942.
9. Zheng HC, Sugawara A, Okamoto H, Takasawa S, Takahashi H, Masuda S, Takano Y. Expression profile of the REG gene family in colorectal carcinoma. J Histochem Cytochem 2011, 59:106-115. 10.1369/jhc.2010.956961, 3201118, 21339177.
10. Bishnupuri KS, Luo Q, Sainathan SK, Kikuchi K, Sureban SM, Sabarinathan M, Gross JH, Aden K, May R, Houchen CW, Anant S, Dieckgraefe BK. Reg IV regulates normal intestinal and colorectal cancer cell susceptibility to radiation-induced apoptosis. Gastroenterology 2010, 138:616-626. 626.e1-2, 10.1053/j.gastro.2009.10.050, 2819553, 19900450.
11. Heiskala K, Arola J, Heiskala M, Andersson LC. Expression of Reg IV and Hath1 in neuroendocrine neoplasms. Histol Histopathol 2010, 25:63-72.
12. Oue N, Sentani K, Noguchi T, Ohara S, Sakamoto N, Hayashi T, Anami K, Motoshita J, Ito M, Tanaka S, Yoshida K, Yasui W. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer 2009, 125:2383-2392. 10.1002/ijc.24624, 19670418.
13. Hayashi T, Matsubara A, Ohara S, Mita K, Hasegawa Y, Usui T, Arihiro K, Norimura S, Sentani K, Oue N, Yasui W. Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker. Oncol Rep. 2009, 21:95-100.
14. Tamura H, Ohtsuka M, Washiro M, Kimura F, Shimizu H, Yoshidome H, Kato A, Seki N, Miyazaki M. Reg IV expression and clinicopathologic features of gallbladder carcinoma. Hum Pathol 2009, 40:1686-1692. 10.1016/j.humpath.2009.06.001, 19716164.
15. Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, Kaneko M, Noguchi T, Nakayama H, Yasui W. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 2005, 207:185-198. 10.1002/path.1827, 16086444.
16. Yuan J, Tu Y, Mao X, He S, Wang L, Fu G, Zong J, Zhang Y. Increased Expression of FAT10 is Correlated with Progression and Prognosis of Human Glioma. Pathol Oncol Res 2012, In press.
17. Li S, Yang B, Li G, He S, Li Y. Downregulation of N-Myc downstream-regulated gene 4 influences patient survival in gliomas. Brain Tumor Pathol 2012, In press.
18. He S, Ding L, Cao Y, Li G, Deng J, Tu Y, Wang B. Overexpression of a disintegrin and metalloprotease 8 in human gliomas is implicated in tumor progression and prognosis. Med Oncol 2011, In press.
19. Nanakin A, Fukui H, Fujii S, et al. Expression of the Reg IV gene in ulcerative colitis. Lab Invest 2007, 87:304-314. 10.1038/labinvest.3700507, 17260007.
20. Sentani K, Oue N, Tashiro T, Sakamoto N, Nishisaka T, Fukuhara T, Taniyama K, Matsuura H, Arihiro K, Ochiai A, Yasui W. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma. Am J Surg Pathol 2008, 32:1182-1189. 10.1097/PAS.0b013e318163a8f8, 18580680.
21. Sasahira T, Oue N, Kirita T, Luo Y, Bhawal UK, Fujii K, Yasui W, Kuniyasu H. Reg IV expression is associated with cell growth and prognosis of adenoid cystic carcinoma in the salivary gland. Histopathology 2008, 53:667-675. 10.1111/j.1365-2559.2008.03188.x, 19076683.
22. Bishnupuri KS, Luo Q, Murmu N, Houchen CW, Anant S, Dieckgraefe BK. Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas. Gastroenterology 2006, 130:137-149. 10.1053/j.gastro.2005.10.001, 16401477.
23. Oue N, Kuniyasu H, Noguchi T, et al. Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis. Oncology 2007, 72:371-380. 10.1159/000113147, 18187959.
24. Zhang Y, Lai M, Lv B, Gu X, Wang H, Zhu Y, Zhu Y, Shao L, Wang G. Overexpression of Reg IV in colorectal adenoma. Cancer Lett 2003, 200:69-76. 10.1016/S0304-3835(03)00460-9, 14550954.
25. Li XH, Zheng Y, Zheng HC, Takahashi H, Yang XH, Masuda S, Takano Y. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study. Histol Histopathol 2010, 25:473-484.
26. Zheng HC, Xu XY, Yu M, Takahashi H, Masuda S, Takano Y. The role of Reg IV gene and its encoding product in gastric carcinogenesis. Hum Pathol 2010, 41:59-69. 10.1016/j.humpath.2009.06.013, 19740514.